Simplex Trading’s Opus Genetics IRD Stock Holding History

Simplex Trading’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,600	Closed	-$17.3K	–	10416
2025 Q4	$17.3K	Buy	+8,600	New	+$17.5K	﹤0.01%	6613
2022 Q2	–	Sell	-1,700	Closed	-$5K	–	11326
2022 Q1	$5K	Sell	1,700 -600	-26%	-$2.05K	﹤0.01%	9472
2021 Q4	$8K	Buy	2,300 +900	+64%	+$3.61K	﹤0.01%	9241
2021 Q3	$7K	Buy	+1,400	New	+$6.46K	﹤0.01%	9151

Other funds holding IRD

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Simplex Trading's IRD Position: Q1 2026 in Review

Simplex Trading increased its Opus Genetics (IRD) stake by 810% in Q1 2026, buying an estimated $254K and bringing the position to 82,480 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

Simplex Trading first reported a position in IRD in Q1 2022 and has held it in 11 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

Simplex Trading held 82,480 shares of Opus Genetics worth $375K as of Q1 2026.
Simplex Trading bought 73,417 Opus Genetics shares in Q1 2026, an estimated $254K.
Opus Genetics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3590 holding.
Simplex Trading first reported a position in Opus Genetics in Q1 2022 and has held it in 11 quarters since.
79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.